Multi-omics of the Frequent Exacerbator Asthmatic
频繁加重哮喘的多组学
基本信息
- 批准号:10197294
- 负责人:
- 金额:$ 45.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-04-09 至 2028-03-31
- 项目状态:未结题
- 来源:
- 关键词:AcuteAffectAsthmaBiologicalCharacteristicsChildChildhoodChildhood AsthmaChronicClinicalClinical ResearchComplexCountyDNADataDeteriorationEconomicsFamilyFoundationsFrequenciesGenesGoalsHealthHealth Care CostsHigh PrevalenceInfrastructureMedicaidMorbidity - disease rateNasal EpitheliumNoseOhioPathway interactionsPatientsPatternPhenotypePublic HealthResearch Project GrantsRiskSiteSteroidsStressSubgroupSymptomsSystemTestingTherapeutic InterventionTranslational ResearchUrban CommunityUrban PopulationVisitacute careasthma exacerbationasthmaticbasecostdesigndifferential expressionexperiencehigh riskhospitalization ratesimprovedinner cityinnovationlower income familiesmethylomemethylomicsmicrobialmortalitymultidisciplinarymultiple omicsnovelpsychologicpulmonary functionrepositoryresearch studysocialsuccesstargeted treatmenttranscriptomics
项目摘要
ABSTRACT
Asthma is a common, complex and costly pediatric chronic condition in the U.S., resulting in nearly 2 million
acute-care visits and $82 billion in overall costs each year. Children of low-income families in urban
communities have the highest prevalence of asthma and the greatest disparities in asthma morbidity and
mortality. In Hamilton County, OH, over 36,000 children have asthma, >14,000 of whom are Medicaid-
insured with a 10-fold higher rate of hospitalization. Asthma exacerbations, acute episodes of increased
asthma symptoms and deteriorations in lung function, are a major cause of stress for patients and families.
While exacerbations are a prominent feature of poorly controlled and severe asthma, exacerbation rates
can be high even in patients with mild asthma and asthma exacerbation frequency can remain unchanged
despite intensive controller therapy. Indeed, pediatric studies have revealed that exacerbations continue
to occur despite good baseline symptom control. A frequent exacerbator phenotype of asthma (defined by
2 or more exacerbations/year), has been described, but little is known about this asthma subgroup, which
disproportionately affects urban populations and is responsible for considerable asthma morbidity and
healthcare costs. No specific clinical characteristics can reliably discriminate between frequent and
nonfrequent exacerbators highlighting the need for systems level approaches. Our center-specific project
will fill this gap in understanding. Our preliminary data reveal differentially expressed and differentially
methylated genes in the nasal epithelial of children who are frequent exacerbators and highlight biologic
pathways that implicate distinct mechanisms that underlie the frequent exacerbator phenotype. We will
test the hypothesis: the frequent exacerbator is a distinct endotype of asthma that is characterized by host
nasal epithelial transcriptomic and/or DNA methylomic patterns that distinguish the frequent exacerbator
from asthmatic children who are not frequent exacerbators, and that these patterns are, in part, triggered
by distinct nasal microbial patterns. We propose an innovative strategy utilizing multiple systems-based
approaches that layer host nasal biome and methylome patterns with nasal epithelial transcriptomics taken
during an acute exacerbation (before administration of steroids). We are uniquely poised to conduct this
study due to the tremendous infrastructure that we have established as part of the Ohio Pediatric Asthma
Repository, and our multidisciplinary team. The overall objective of our studies is to improve the lives of
children with asthma from low-income families who live in urban communities. We propose to 2 aims: (1)
To contribute to the overall CAUSE goals by conducting network-wide CAUSE clinical research projects
and participating in the CAUSE Steering Committee and other network functions; (2) To conduct a center-
specific project aligned with CAUSE goals focused on the frequent exacerbator asthma phenotype.
抽象的
哮喘是美国常见,复杂且昂贵的儿科慢性病,导致近200万
急性护理访问和每年820亿美元的总成本。城市低收入家庭的孩子
社区的哮喘患病率最高,哮喘发病率最大
死亡。在俄亥俄州汉密尔顿县,超过36,000名儿童患有哮喘,其中14,000人是医疗补助
保险率高10倍。哮喘恶化,急性发作增加
肺功能的哮喘症状和恶化,是患者和家庭压力的主要原因。
虽然恶化是控制较差和严重哮喘的突出特征,但加剧率
即使患有轻度哮喘和哮喘恶化频率的患者也可能很高
尽管进行了密集的控制器疗法。确实,小儿研究表明,恶化继续
尽管控制良好,但仍会发生。哮喘的频繁恶化表型(由
已经描述了2个或以上的加重/年),但对此哮喘亚组知之甚少
不成比例地影响城市人口,并负责大量的哮喘发病率和
医疗保健费用。没有特定的临床特征可以可靠地区分频繁和
非频繁的加剧者强调了对系统级方法的需求。我们的中心特定项目
将填补这一差距。我们的初步数据揭示了差异表达和差异
频繁恶化并突出生物学的儿童的鼻皮上上皮中的甲基化基因
涉及频繁恶化表型基础的不同机制的途径。我们将
测试假设:频繁的恶化是哮喘的独特内部型,以主机为特征
鼻上皮转录组和/或DNA甲基甲基组模式,区分频繁的恶化
从不常见的哮喘儿童出发,这些模式在某种程度上触发了
通过不同的鼻微生物模式。我们提出了一种利用多个基于系统的创新策略
该层的方法具有鼻上皮转录组学的鼻腔生物组和甲基化模式
在急性加重期间(服用类固醇)。我们有独特的准备进行
由于我们已确立为俄亥俄州小儿哮喘的一部分的巨大基础设施而导致的研究
存储库和我们的多学科团队。我们研究的总体目的是改善
居住在城市社区的低收入家庭哮喘的儿童。我们提出2个目标:(1)
通过进行网络范围的临床研究项目来促进总体原因目标
并参加因果指导委员会和其他网络职能; (2)进行中心 -
特定的项目与因素目标一致,该目标集中在频繁的恶化哮喘表型上。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Gurjit K. Khurana Hershey其他文献
Simultaneous skin biome and keratinocyte genomic capture reveals microbiome differences by depth of sampling
- DOI:
10.1016/j.jaci.2020.04.004 - 发表时间:
2020-12-01 - 期刊:
- 影响因子:
- 作者:
Mariana L. Stevens;Tammy Gonzalez;Eric Schauberger;Asel Baatyrbek kyzy;Heidi Andersen;Daniel Spagna;Mehak K. Kalra;Lisa J. Martin;David Haslam;Andrew B. Herr;Jocelyn M. Biagini Myers;Gurjit K. Khurana Hershey - 通讯作者:
Gurjit K. Khurana Hershey
Immunodeficiency: a problem with the faucet or the drain?
- DOI:
10.1016/j.anai.2011.09.016 - 发表时间:
2011-12-01 - 期刊:
- 影响因子:
- 作者:
Burcin Uygungil;Amal Assa'Ad;Gurjit K. Khurana Hershey;Kimberly Risma - 通讯作者:
Kimberly Risma
High number of early respiratory infections in association with allergic sensitization to mold promotes childhood asthma
- DOI:
10.1016/j.jaci.2017.11.058 - 发表时间:
2018-05-01 - 期刊:
- 影响因子:
- 作者:
Leilanie Perez Ramirez;Heepke Wendroth;Lisa J. Martin;Valentina V. Pilipenko;Hua He;John Kroner;Patrick H. Ryan;Grace K. LeMasters;James E. Lockey;David I. Bernstein;Gurjit K. Khurana Hershey;Jocelyn M. Biagini Myers - 通讯作者:
Jocelyn M. Biagini Myers
What allergists/immunologists can do to limit the effects of air pollution on asthma and allergies
- DOI:
10.1016/j.anai.2023.11.019 - 发表时间:
2024-04-01 - 期刊:
- 影响因子:
- 作者:
Michael Sherenian;Jocelyn M. Biagini;Patrick Ryan;Gurjit K. Khurana Hershey - 通讯作者:
Gurjit K. Khurana Hershey
Best Practices in Recruitment of the First US-Based Atopic Dermatitis Cohort: The Mechanisms of Progression of Atopic Dermatitis to Asthma in Children (MPAACH).
- DOI:
10.1016/j.jaci.2017.12.966 - 发表时间:
2018-02-01 - 期刊:
- 影响因子:
- 作者:
Asel Baatyrbek-kyzy;Rosario Alarcon;Alexandria Patterson;Kristina Keidel;John Kroner;Gurjit K. Khurana Hershey;Jocelyn M. Biagini Myers - 通讯作者:
Jocelyn M. Biagini Myers
Gurjit K. Khurana Hershey的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Gurjit K. Khurana Hershey', 18)}}的其他基金
Atopic dermatitis: mechanisms of disease progression
特应性皮炎:疾病进展的机制
- 批准号:
10379962 - 财政年份:2020
- 资助金额:
$ 45.2万 - 项目类别:
Atopic dermatitis: mechanisms of disease progression
特应性皮炎:疾病进展的机制
- 批准号:
10596577 - 财政年份:2020
- 资助金额:
$ 45.2万 - 项目类别:
Atopic dermatitis: mechanisms of disease progression
特应性皮炎:疾病进展的机制
- 批准号:
9974832 - 财政年份:2020
- 资助金额:
$ 45.2万 - 项目类别:
Role and Regulation of TSLP in Childhood Allergic Disease
TSLP在儿童过敏性疾病中的作用和调节
- 批准号:
10307538 - 财政年份:2017
- 资助金额:
$ 45.2万 - 项目类别:
Role and Regulation of TSLP in Childhood Allergic Disease
TSLP在儿童过敏性疾病中的作用和调节
- 批准号:
10063471 - 财政年份:2017
- 资助金额:
$ 45.2万 - 项目类别:
相似国自然基金
LPGAT1介导的磷脂重塑影响Treg细胞分化及功能参与哮喘发病机制研究
- 批准号:82370032
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
咳喘停穴位贴敷通过PI3K/AKT/c-Rel调控ILC2s-ICOSL影响Th2免疫应答参与过敏性哮喘的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
哮喘易感转录因子Bach2调控Treg细胞影响气道高反应性的作用机制研究
- 批准号:82270027
- 批准年份:2022
- 资助金额:53.00 万元
- 项目类别:面上项目
哮喘患者痛觉异常对电针疗效影响的动态脑效应机制研究
- 批准号:82205267
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
固本防哮饮调控RTN4B介导鞘脂代谢稳态影响哮喘气道重塑的机制研究
- 批准号:82205186
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
相似海外基金
Obesity and Childhood Asthma: The Role of Adipose Tissue
肥胖和儿童哮喘:脂肪组织的作用
- 批准号:
10813753 - 财政年份:2023
- 资助金额:
$ 45.2万 - 项目类别:
Heterogeneity and cellular hierarchy of lung cDC2
肺 cDC2 的异质性和细胞层次
- 批准号:
10665348 - 财政年份:2023
- 资助金额:
$ 45.2万 - 项目类别:
Dose escalation clinical trial of high-dose oral montelukast to inform future RCT in children with acute asthma exacerbations
大剂量口服孟鲁司特的剂量递增临床试验为哮喘急性发作儿童的未来随机对照试验提供信息
- 批准号:
10649012 - 财政年份:2023
- 资助金额:
$ 45.2万 - 项目类别:
Extraction of Vital Signs using a Telehealth Application for Asthma - EViTA-AThe purpose of this grant is to evaluate mobile devices to extract vitals signs to monitor patients with Asthma
使用哮喘远程医疗应用程序提取生命体征 - EViTA-A 这项拨款的目的是评估移动设备提取生命体征以监测哮喘患者
- 批准号:
10699530 - 财政年份:2023
- 资助金额:
$ 45.2万 - 项目类别: